Increased synaptic dopamine in the putamen in restless legs syndrome

Sleep

Volumn 36, Issue 1, 2013, Pages 51-57

  Earley, Christopher J ^a   Kuwabara, Hiroto ^a   Wong, Dean F ^a   Gamaldo, Charlene ^a   Salas, Rachel E ^a   Brašíc, James R ^a   Ravert, Hayden T ^a   Dannals, Robert F ^a   Allen, Richard P ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diurnal; Dopamine receptor; Positron emission tomography; Restless legs syndrome; Striatum

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; RACLOPRIDE C 11;

ADULT; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE SEVERITY; FEMALE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PUTAMEN; RESTLESS LEGS SYNDROME; SLEEP;

BASAL GANGLIA; CIRCADIAN RHYTHM; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RECEPTORS, DOPAMINE D2; RESTLESS LEGS SYNDROME; SYNAPSES;

EID: 84871909837     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2300     Document Type: Article

References (47)

1. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005;165:1286-92. (Pubitemid 40989594)
2. Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000;62:623-8.
3. Trenkwalder C, Earley CJ. Neuroimaging in Restless Legs Syndrome. In: Hening WA, Allen RP, Chokroverty S, Earley CJ, eds. Restless Legs Syndrome. Philadelphia: Saunders Elsevier; 2009:78-82.
4. Connor JR, Wang XS, Allen RP, et al. Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome. Brain 2009;132:2403-12.
5. Farde L, Hall H, Pauli S, Halldin C. Variability in D2-dopamine receptor density and affinity: a PET study with [11C]raclopride in man. Synapse 1995;20:200-8.
6. Hietala J, Nagren K, Lehikoinen P, Ruotsalainen U, Syvalahti E. Measurement of Striatal D2 Dopamine Receptor Density and Affinity with [11C]-Raclopride in Vivo: A Test-Retest Analysis. J Cereb Blood Flow Metab 1999;19:210-7. (Pubitemid 29284269)
7. Laruelle M. Dopamine transmission in the schizophrenic brain. In: Hirsch S, Weinberger D, eds. Schizophrenia. Oxford: Blackwell; 2003:365-87.
8. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 2001;18:128-47. (Pubitemid 32549908)
9. Lynoe N, Sandlund M, Dahlqvist G, Jacobsson L. Informed consent: study of quality of information given to participants in a clinical trial. Bmj 1991;303:610-3.
10. Hening WA, Allen RP, Washburn M, Lesage S, Earley CJ. Validation of the Hopkins telephone diagnostic interview for restless legs syndrome. Sleep Medicine 2008;9:283-9. (Pubitemid 351391728)
11. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19. (Pubitemid 36527231)
12. Allen RP, Hening WA. Actigraph assessment of periodic leg movements and restless legs syndrome. In: Hening WA, Allen RP, Chokroverty S, Earley CJ, eds. Restless Legs Syndrome. Philadelphia: Saunders Elsevier; 2009:142-9.
13. Earley CJ, Horska A, Mohamed MA, Barker PB, Beard JL, Allen RP. A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome. Sleep Med 2009;10:206-11.
14. Hilton J, Yokoi F, Dannals RF, Ravert HT, Szabo Z, Wong DF. Column-switching HPLC for the analysis of plasma in PET imaging studies. Nucl Med Biol 2000;27:627-30.
15. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-406. (Pubitemid 24243158)
16. Ehrin E, Farde L, de Paulis T, et al. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot 1985;36:269-73.
17. Oswald LM, Wong DF, McCaul M, et al. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Neuropsychopharmacology 2005;30:821-32. (Pubitemid 40397089)
18. Mawlawi O, Martinez D, Slifstein M, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001;21:1034-57. (Pubitemid 32823740)
19. Martinez D, Slifstein M, Broft A, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003;23:285-300. (Pubitemid 36307573)
20. Baumann B, Danos P, Krell D, et al. Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a post-mortem study. J Neuropsychiatry Clin Neurosci 1999;11:71-8. (Pubitemid 29070667)
21. Ashburner JT, Friston KJ. Rigid body registration. In: Friston KJ, Ashburner JT, Kiebel SJ, Nichols TE, eds. Statistical Parametric Mapping: The Analysis of Functional Brain Images. Boston: Academic Press; 2007:49-62.
22. Ichise M, Liow JS, Lu JQ, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003;23:1096-112. (Pubitemid 37082435)
23. Kuwabara H, McCaul ME, Wand GS, et al. Dissociative changes in Bmax and KD of dopamine D2/D3 receptors with aging observed in functional subdivisions of striatum: A revisit with an improved data analysis method. Journal of Nuclear Medicine 2012; In Press.
24. Carson RE, Channing MA, Blasberg RG, et al. Comparison of bolus and infusion methods for receptor quantitation: application to [18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993;13:24-42. (Pubitemid 23016600)
25. Staedt J, Stoppe G, Kogler A, et al. Dopamine D2 receptor alterations in patients with periodic movements in sleep (nocturnal myoclonus). J Neural Transm Gen Sect 1993;93:71-4. (Pubitemid 23235620)
26. Staedt J, Stoppe G, Kogler A, et al. Single photon emission tomography (SPET) imaging of dopamine D2 receptors in the course of dopamine replacement therapy in patients with nocturnal myoclonus syndrome (NMS). J Neural Transm Gen Sect 1995;99:187-93.
27. Staedt J, Stoppe G, Kogler A, et al. Nocturnal myoclonus syndrome (periodic movements in sleep) related to central dopamine D2-receptor alteration. Eur Arch Psychiatry Clin Neurosci 1995;245:8-10.
28. Michaud M, Soucy JP, Chabli A, Lavigne G, Montplaisir J. SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep. J Neurol 2002;249:164-70. (Pubitemid 34143470)
29. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies. Neurology 1999;52:932-7. (Pubitemid 29161599)
30. Eisensehr I, Wetter TC, Linke R, et al. Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome. Neurology 2001;57:1307-9. (Pubitemid 32947394)
31. Tribl GG, Asenbaum S, Klosch G, et al. Normal IPT and IBZM SPECT in drug naive and levodopa-treated idiopathic restless legs syndrome (letter to editor). Neurology 2002;59:649-50. (Pubitemid 34920017)
32. Cervenka S, Palhagen SE, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain 2006;129:2017-28. (Pubitemid 44289067)
33. Wong DF, Wagner HN, Dannals R, et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984;226:1393-6. (Pubitemid 15161272)
34. Eisensehr I, Ehrenberg BL, Noachtar S. Different sleep characteristics in restless legs syndrome and periodic limb movement disorder. Sleep Med 2003;4:147-52. (Pubitemid 36527236)
35. Volkow ND, Wang G-J, Telang F, et al. Sleep deprivation decreases binding of [11C]raclopride to dopamine D2/D3 receptors in the human brain. J Neurosci 2008;28:8454-61.
36. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-51. (Pubitemid 30164887)
37. Verhoeff NP, Kapur S, Hussey D, et al. A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology 2001;25:213-23. (Pubitemid 32566343)
38. Volkow ND, Tomasi D, Wang G-J, et al. Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment. NeuroImage 2009;45:1232-40.
39. Earley CJ, Hyland K, Allen RP. Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med 2006;7:263-8.
40. Cooper JR, Bloom FE, Roth RH. The Biochemical Basis of Neuropharmacology. 8th ed. New York: Oxford University Press; 2003.
41. Ruottinen HM, Partinen M, Hublin C, et al. An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology 2000;54:502-4. (Pubitemid 30078095)
42. Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Earley CJ. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-9. (Pubitemid 36975956)
43. Earley CJ, Kuwabara H, Wong DF, et al. The dopamine transporter is decreased in the striatum of subjects with restless legs syndrome. Sleep 2011;34:341-7.
44. Wirz-Justice A. Circadian rhythms in mammalian neurotransmitter receptors. Prog Neurobiol 1987;29:219-59.
45. Planeta CS, DeLucia R, Aizenstein ML, Oliveira GH. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptors in rats. Braz J Med Biol Res 1994;27:737-41. (Pubitemid 24115409)
46. Akhisaroglu M, Kurtuncu M, Manev H, Uz T. Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol Biochem Behav 2005;80:371-7. (Pubitemid 40299337)
47. Červenka S, Halldin C, Farde L. Age-related diurnal effect on D2 receptor binding: a preliminary PET study. The International Journal of Neuropsychopharmacology 2008;11:671-8. (Pubitemid 351931821)